Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Conditions: Colitis, Ulcerative Interventions: Drug: Mesalazine Sponsors: Faes Farma, S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials